Welcome to beacies
The term “beacies” derives from the word “beacon,” which represents the intrinsic capability of “beacies” to highlight otherwise undetectable targets. These molecules function as genuine “guiding lights in the night,” aiming to reveal invisible targets in a more sensitive and targeted manner.
We offer personalized chromophoric VHH derivatives and HRP/Fc-conjugated VHHs for research and diagnostic applications. Our products allow high-resolution in vitro and in vivo tracing of specific cellular proteins. Talk to us to find out which product best fits your planned applications: we tailor our products and services to our client’s needs.
preclinics Italia srl is an innovative start-up company based in Parma, Italy.
Building on the expertise of her CEO, Valentina Garrapa PhD, the Italian team has developed a strong competence in the field of recombinant antibody selection, production and purification, especially regarding the variable domains of camelid antibodies (VHHs) and their derivatives.
Our major strength is the capacity to produce VHH derivatives for biomedical diagnostic and research applications. In particular, engineered VHH conjugated with near-infrared fluorescent proteins (NIRFPs), horseradish peroxidase (HRP) and IgG-derived FC domains.
In our services, we always aim at close collaboration with our customers to meet their specific needs in a personalized manner.
Stemming from a collaborative project with the University of Parma, preclinics Italia srl is located on the Science and Technology Campus of UNIPR in a modern and stimulating environment.
Our staff is young, always up-to-date, and cares to provide the customers with personalized services.
The Italian branch of preclinics specializes in the production and purification of recombinant antibodies, in particular variable domains of camelid antibodies (VHH) and their derivatives.
With the help of our experts in molecular biology and recombinant DNA technologies, we will advise you on the right approach for the production of your native, fusion or recombinant antibody, evaluating different hosts for expression including E. coli and yeast.
Our Team
